A N Viswanathan

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Night shift work and the risk of endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer Res 67:10618-22. 2007
  2. pmc Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
    Cancer Res 68:2507-13. 2008
  3. pmc Concurrent chemoradiation for vaginal cancer
    David T Miyamoto
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, United States of America
    PLoS ONE 8:e65048. 2013
  4. doi request reprint A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA Electronic address
    Gynecol Oncol 132:55-60. 2014
  5. doi request reprint Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospita and Dana Farber Cancer Institutel, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 130:545-9. 2013
  6. doi request reprint A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, MA 02115, USA
    Brachytherapy 12:240-7. 2013
  7. doi request reprint The importance of chemotherapy and radiation in uterine papillary serous carcinoma
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 123:542-7. 2011
  8. doi request reprint Advances in the use of radiation for gynecologic cancers
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Hematol Oncol Clin North Am 26:157-68. 2012
  9. pmc The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128
    Akila N Viswanathan
    Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Int J Gynecol Cancer 22:123-31. 2012
  10. pmc Circulating melatonin and the risk of breast and endometrial cancer in women
    Akila N Viswanathan
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Cancer Lett 281:1-7. 2009

Detail Information

Publications30

  1. ncbi request reprint Night shift work and the risk of endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Boston, MA 02115, USA
    Cancer Res 67:10618-22. 2007
    ..Our results add to growing literature that suggests women who work at night may benefit from cancer prevention strategies...
  2. pmc Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute and Harvard Medical School, Boston, MA, USA
    Cancer Res 68:2507-13. 2008
    ..However, risk was significantly lower for current aspirin users who were obese or who were postmenopausal and had never used PMHs; these subgroup findings require further confirmation...
  3. pmc Concurrent chemoradiation for vaginal cancer
    David T Miyamoto
    Harvard Radiation Oncology Program, Harvard Medical School, Boston, Massachusetts, United States of America
    PLoS ONE 8:e65048. 2013
    ..Here, we review clinical outcomes in patients with primary vaginal cancer treated with radiation therapy (RT) or concurrent chemoradiation therapy (CRT)...
  4. doi request reprint A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA Electronic address
    Gynecol Oncol 132:55-60. 2014
    ..To determine the toxicity and survival rates in a trial of concurrent bevacizumab and external beam radiation (EB) for patients with recurrent endometrial or ovarian cancer...
  5. doi request reprint Relationship of margin status and radiation dose to recurrence in post-operative vulvar carcinoma
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospita and Dana Farber Cancer Institutel, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 130:545-9. 2013
    ..To evaluate the effect of margin status and radiation dose in patients treated with radiation therapy (RT) for vulvar cancer. Clinical outcomes included vulvar recurrence (VR), relapse-free survival (RFS) and overall survival (OS)...
  6. doi request reprint A prospective trial of real-time magnetic resonance-guided catheter placement in interstitial gynecologic brachytherapy
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, MA 02115, USA
    Brachytherapy 12:240-7. 2013
    ..To present outcome and toxicity results of the first real-time intraoperative MRI-guided interstitial approach to gynecologic cancer...
  7. doi request reprint The importance of chemotherapy and radiation in uterine papillary serous carcinoma
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Gynecol Oncol 123:542-7. 2011
    ..To identify prognostic and predictive factors of overall survival (OS), relapse-free survival (RFS) and toxicity for patients with uterine papillary serous carcinoma (UPSC)...
  8. doi request reprint Advances in the use of radiation for gynecologic cancers
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Hematol Oncol Clin North Am 26:157-68. 2012
    ....
  9. pmc The quality of cervical cancer brachytherapy implantation and the impact on local recurrence and disease-free survival in radiation therapy oncology group prospective trials 0116 and 0128
    Akila N Viswanathan
    Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
    Int J Gynecol Cancer 22:123-31. 2012
    ..The objective of the study was to determine the impact of brachytherapy implant quality on outcome among cervical cancer patients treated on Radiation Therapy Oncology Group prospective trials 0116 and 0128...
  10. pmc Circulating melatonin and the risk of breast and endometrial cancer in women
    Akila N Viswanathan
    Department of Radiation Oncology, Dana Farber Cancer Institute and Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
    Cancer Lett 281:1-7. 2009
    ..Additional studies are needed to delineate further the potential of melatonin in cancer prevention...
  11. ncbi request reprint Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute and Harvard Medical School, 75 Francis St, Boston, MA 02115, USA
    Radiographics 28:289-307. 2008
  12. doi request reprint Increasing brachytherapy dose predicts survival for interstitial and tandem-based radiation for stage IIIB cervical cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Gynecol Cancer 19:1402-6. 2009
    ..To evaluate factors affecting survival and toxicity in patients with stage IIIB cervical cancer treated with external-beam radiotherapy and low-dose-rate brachytherapy...
  13. pmc Radiation dose-volume effects of the urinary bladder
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute and Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 76:S116-22. 2010
    ..The data on partial-organ/nonuniform irradiation are suspect because the bladder motion is not accounted for, and many studies lack long enough follow-up data. Future studies are needed...
  14. ncbi request reprint The Frank Ellis memorial lecture: the use of three-dimensional imaging in gynaecological radiation therapy
    A N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, Harvard Medical School, 75 Francis Street L2, Boston, MA 02115, USA
    Clin Oncol (R Coll Radiol) 20:1-5. 2008
    ..This lecture will focus on novel advances in three-dimensional image-guided radiation therapy for cervical cancer, with the ultimate goal of improving outcomes for our patients...
  15. pmc International brachytherapy practice patterns: a survey of the Gynecologic Cancer Intergroup (GCIG)
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 82:250-5. 2012
    ....
  16. doi request reprint Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 76:104-9. 2010
    ..To determine current practice patterns with regard to three-dimensional (3D) imaging for gynecologic brachytherapy among American Brachytherapy Society (ABS) members...
  17. pmc Correlation of point B and lymph node dose in 3D-planned high-dose-rate cervical cancer brachytherapy
    Larissa J Lee
    Harvard Radiation Oncology Program, Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, 75 Francis Street, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 75:803-9. 2009
    ..To compare high dose rate (HDR) point B to pelvic lymph node dose using three-dimensional-planned brachytherapy for cervical cancer...
  18. ncbi request reprint Magnetic resonance-guided interstitial therapy for vaginal recurrence of endometrial cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 66:91-9. 2006
    ..To evaluate the feasibility and to describe the acute toxicity of a real-time intraoperative magnetic resonance (MR)-image guided interstitial approach to treating vaginal recurrence of endometrial cancer...
  19. ncbi request reprint Computed tomography versus magnetic resonance imaging-based contouring in cervical cancer brachytherapy: results of a prospective trial and preliminary guidelines for standardized contours
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 68:491-8. 2007
    ..To compare the contours and dose-volume histograms (DVH) of the tumor and organs at risk (OAR) with computed tomography (CT) vs. magnetic resonance imaging (MRI) in cervical cancer brachytherapy...
  20. pmc Sigmoid dose using 3D imaging in cervical-cancer brachytherapy
    Caroline L Holloway
    Department of Radiation Oncology, Brigham and Women s Hospital Dana Farber Cancer Institute, MA, USA
    Radiother Oncol 93:307-10. 2009
    ..To evaluate the proximity, variance, predictors of dose, and complications to the sigmoid in cervical-cancer brachytherapy using 3D planning...
  21. ncbi request reprint Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA, USA
    Gynecol Oncol 93:27-33. 2004
    ..To analyze the sites of relapse and overall survival in women with neuroendocrine marker-positive small cell carcinoma of the cervix...
  22. pmc Prospective clinical trial of bladder filling and three-dimensional dosimetry in high-dose-rate vaginal cuff brachytherapy
    Alexandra J Stewart
    Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, and Harvard Medical School, Boston, MA, USA
    Int J Radiat Oncol Biol Phys 72:843-8. 2008
    ..To investigate the effect of bladder filling on dosimetry and to determine the best bladder dosimetric parameter for vaginal cuff brachytherapy...
  23. ncbi request reprint Influence of margin status and radiation on recurrence after radical hysterectomy in Stage IB cervical cancer
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 65:1501-7. 2006
    ..To examine the relationship between margin status and local recurrence (LR) or any recurrence after radical hysterectomy (RH) in women treated with or without radiotherapy (RT) for Stage IB cervical carcinoma...
  24. ncbi request reprint Current controversies in high-dose-rate versus low-dose-rate brachytherapy for cervical cancer
    Alexandra J Stewart
    Department of Radiation Oncology, Brigham and Women s Hospital, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Cancer 107:908-15. 2006
    ....
  25. ncbi request reprint Synovial cell sarcoma of the vulva: multimodality treatment incorporating preoperative external-beam radiation, hemivulvectomy, flap reconstruction, interstitial brachytherapy, and chemotherapy
    Caroline L Holloway
    Department of Radiation Oncology, Brigham and Women s Hospital and Dana Farber Cancer Institute, Harvard Medical School, 75 Francis Street L2, Boston, Massachusetts, MA 02115, USA
    Gynecol Oncol 104:253-6. 2007
    ..Vulvar synovial cell sarcomas are rare, with only four previously published cases in the literature. Traditionally, the primary management for these tumors has been surgery alone...
  26. doi request reprint Outcomes after radiation therapy with concurrent weekly platinum-based chemotherapy or every-3-4-week 5-fluorouracil-containing regimens for squamous cell carcinoma of the vulva
    Raymond H Mak
    Harvard Radiation Oncology Program, Boston, MA, USA
    Gynecol Oncol 120:101-7. 2011
    ..To compare outcomes in patients with squamous cell carcinoma (SCC) of the vulva treated with radiation (RT) and concurrent weekly platinum-based or every-3-4-week regimens containing 5-fluorouracil (5-FU)...
  27. doi request reprint Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival
    Martin C Chang
    Division of Women s and Perinatal Pathology, Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Int J Gynecol Pathol 29:88-92. 2010
    ..Extensive, recurring AIS is a rare variant that may be unique for its risk of coincident ovarian involvement. However, ovarian spread, albeit rare, does not invariably result in an adverse outcome...
  28. ncbi request reprint Outcome for children with group III rhabdomyosarcoma treated with or without radiotherapy
    Akila N Viswanathan
    Department of Radiation Oncology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Int J Radiat Oncol Biol Phys 58:1208-14. 2004
    ..To analyze the sites of relapse, relapse-free survival, and overall survival in children with Group III rhabdomyosarcoma treated with or without radiotherapy (RT)...
  29. doi request reprint Computed tomography-based radiation therapy of ovarian remnants for symptomatic persistent endometriosis
    Karl E Haglund
    Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA
    Obstet Gynecol 111:579-83. 2008
    ..Endometriosis, a major cause of pelvic pain in women, is driven by estrogen. Ovarian remnant irradiation may alleviate pelvic pain by eliminating estrogen production in appropriately selected women with endometriosis...
  30. ncbi request reprint Smoking and the risk of endometrial cancer: results from the Nurses' Health Study
    Akila N Viswanathan
    Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
    Int J Cancer 114:996-1001. 2005
    ..The findings provide insight into disease etiology and suggest that the influence of smoking on endometrial cancer risk occurs even in early adulthood, is long-lasting, and may not be attributed solely to short-term hormonal modulation...